Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

Novel strategies have been developed to reduce or avoid intravitreal injections (IVTs) of the antiangiogenic (ranibizumab (RBZ)) and anti-inflammatory (triamcinolone acetonide (TA)) agents used to treat vitreoretinal diseases. One of the strategies includes liposomes. This study evaluated the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Partida, Jose, Altamirano-Vallejo, Juan Carlos, Aceves Franco, Luis Abraham, Gonzalez-Cortes, Jesús, Hernandez-Da Mota, Sergio, García-Aguirre, Jose Gerardo, Azuara-Galindo, Carlos David, Castro-Castaneda, Carlos Rodrigo, Armendariz-Borunda, Juan, Santos, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471461/
https://www.ncbi.nlm.nih.gov/pubmed/34575567
http://dx.doi.org/10.3390/pharmaceutics13091491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471461/
https://www.ncbi.nlm.nih.gov/pubmed/34575567
http://dx.doi.org/10.3390/pharmaceutics13091491

Ejemplares similares